Although these findings come from a single randomized clinical trial conducted in a specific patient population, they contribute to ongoing research in this area
Track your progress: Use a journal or app to note how you feel, your energy levels, and your appetite changes
Cardiovascular disease - the leading global cause of death Nonetheless, use of semaglutide could help address CVD, which remains the leading cause of mortality around the world, and obesity, which is still an epidemic, Cynthia Jackevicius of Western University of Health Sciences emphasised the potential population impact of semaglutide, stating that it could have a profound effect on reducing morbidity and mortality from cardiovascular disease
Product hopping shifts patient prescriptions to a new, patented version of a drug before generics can enter on the old formulation
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways There is no evidence that semaglutide directly affects the menstrual cycle
The most commonly reported side effects in Phase 2 trials were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and tended to improve over time
